🚀 VC round data is live in beta, check it out!
Biotalys Valuation Multiples
Discover revenue and EBITDA valuation multiples for Biotalys and similar public comparables like Groupe Minoteries, UBM Holding, PGG Wrightson, Livestock Improvement and more.
Biotalys Overview
About Biotalys
Biotalys NV is an agricultural technology company focused on addressing food protection challenges with proprietary protein-based biocontrol solutions and aiming to provide alternatives to conventional chemical pesticides for a more sustainable and safer food supply.
Founded
2013
HQ
Employees
64
Website
Sectors
Financials (LTM)
EV
$83M
Biotalys Financials
Biotalys reported last 12-month revenue of $4M and negative EBITDA of ($15M).
In the same LTM period, Biotalys generated $4M in gross profit, ($15M) in EBITDA losses, and had net loss of ($16M).
Revenue (LTM)
Biotalys P&L
In the most recent fiscal year, Biotalys reported revenue of $3M and EBITDA of ($12M).
Biotalys expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $4M | XXX | $3M | XXX | XXX | XXX |
| Gross Profit | $4M | XXX | — | XXX | XXX | XXX |
| Gross Margin | 100% | XXX | — | XXX | XXX | XXX |
| EBITDA | ($15M) | XXX | ($12M) | XXX | XXX | XXX |
| EBITDA Margin | (400%) | XXX | (346%) | XXX | XXX | XXX |
| EBIT Margin | (442%) | XXX | (435%) | XXX | XXX | XXX |
| Net Profit | ($16M) | XXX | ($14M) | XXX | XXX | XXX |
| Net Margin | (428%) | XXX | (407%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Biotalys Stock Performance
Biotalys has current market cap of $99M, and enterprise value of $83M.
Market Cap Evolution
Biotalys' stock price is $2.63.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $83M | $99M | 0.0% | XXX | XXX | XXX | $-0.36 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialBiotalys Valuation Multiples
Biotalys trades at 22.4x EV/Revenue multiple, and (5.6x) EV/EBITDA.
EV / Revenue (LTM)
Biotalys Financial Valuation Multiples
As of April 19, 2026, Biotalys has market cap of $99M and EV of $83M.
Equity research analysts estimate Biotalys' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Biotalys has a P/E ratio of (6.3x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $99M | XXX | $99M | XXX | XXX | XXX |
| EV (current) | $83M | XXX | $83M | XXX | XXX | XXX |
| EV/Revenue | 22.4x | XXX | 24.5x | XXX | XXX | XXX |
| EV/EBITDA | (5.6x) | XXX | (7.1x) | XXX | XXX | XXX |
| EV/EBIT | (5.1x) | XXX | (5.6x) | XXX | XXX | XXX |
| EV/Gross Profit | 22.4x | XXX | — | XXX | XXX | XXX |
| P/E | (6.3x) | XXX | (7.2x) | XXX | XXX | XXX |
| EV/FCF | (4.6x) | XXX | (5.9x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Biotalys Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Biotalys Margins & Growth Rates
Biotalys' revenue in the last 12 month grew by 58%.
Biotalys' revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.2M for the same period.
Biotalys' rule of 40 is (140%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Biotalys' rule of X is (16%) (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Biotalys Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 58% | XXX | (12%) | XXX | XXX | XXX |
| EBITDA Margin | (400%) | XXX | (346%) | XXX | XXX | XXX |
| EBITDA Growth | (19%) | XXX | 37% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | (140%) | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | (16%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 0% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 200% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 408% | XXX | 383% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 471% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Biotalys Public Comps
See public comps and valuation multiples for other Agriculture comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Biotalys | XXX | XXX | XXX | XXX | XXX | XXX |
| Groupe Minoteries | XXX | XXX | XXX | XXX | XXX | XXX |
| UBM Holding | XXX | XXX | XXX | XXX | XXX | XXX |
| PGG Wrightson | XXX | XXX | XXX | XXX | XXX | XXX |
| Livestock Improvement | XXX | XXX | XXX | XXX | XXX | XXX |
| Paramonga | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Biotalys M&A Activity
Biotalys acquired XXX companies to date.
Last acquisition by Biotalys was on XXXXXXXX, XXXXX. Biotalys acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Biotalys
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialBiotalys Investment Activity
Biotalys invested in XXX companies to date.
Biotalys made its latest investment on XXXXXXXX, XXXXX. Biotalys invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Biotalys
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Biotalys
| When was Biotalys founded? | Biotalys was founded in 2013. |
| Where is Biotalys headquartered? | Biotalys is headquartered in Belgium. |
| How many employees does Biotalys have? | As of today, Biotalys has over 64 employees. |
| Who is the CEO of Biotalys? | Biotalys' CEO is Kevin Helash. |
| Is Biotalys publicly listed? | Yes, Biotalys is a public company listed on Euronext Brussels. |
| What is the stock symbol of Biotalys? | Biotalys trades under BTLS ticker. |
| When did Biotalys go public? | Biotalys went public in 2021. |
| Who are competitors of Biotalys? | Biotalys main competitors are Groupe Minoteries, UBM Holding, PGG Wrightson, Livestock Improvement. |
| What is the current market cap of Biotalys? | Biotalys' current market cap is $99M. |
| What is the current revenue of Biotalys? | Biotalys' last 12 months revenue is $4M. |
| What is the current revenue growth of Biotalys? | Biotalys revenue growth (NTM/LTM) is 58%. |
| What is the current EV/Revenue multiple of Biotalys? | Current revenue multiple of Biotalys is 22.4x. |
| Is Biotalys profitable? | No, Biotalys is not profitable. |
| What is the current EBITDA of Biotalys? | Biotalys has negative EBITDA and is not profitable. |
| What is Biotalys' EBITDA margin? | Biotalys' last 12 months EBITDA margin is (400%). |
| What is the current EV/EBITDA multiple of Biotalys? | Current EBITDA multiple of Biotalys is (5.6x). |
| What is the current FCF of Biotalys? | Biotalys' last 12 months FCF is ($18M). |
| What is Biotalys' FCF margin? | Biotalys' last 12 months FCF margin is (488%). |
| What is the current EV/FCF multiple of Biotalys? | Current FCF multiple of Biotalys is (4.6x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.